-16.7 | | Slc17a3 | 'status epilepticus' vs 'none' in 'microglia; none' | cell type, compound, disease | RNA-seq profiling of three distinct cell populations in a murine model of epilepsia with and without drug treatment |
-16.2 | | Slc17a3 | 'soticlestat; 30 milligram per kilogram' vs 'none' in 'microglia; none' | cell type, compound, disease | RNA-seq profiling of three distinct cell populations in a murine model of epilepsia with and without drug treatment |
-10.4 | | Slc17a3 | 'status epilepticus' vs 'none' in 'astrocyte; soticlestat; 30 milligram per kilogram' | cell type, compound, disease | RNA-seq profiling of three distinct cell populations in a murine model of epilepsia with and without drug treatment |
-7 | | Slc17a3 | 'transplanted secondary tumors' vs 'normal' in 'kidney' | clinical information, organism part | Premature termination of in vivo reprogramming leads to cancer development through altered epigenetic regulation [array] |
-5.1 | | Slc17a3 | 'Albumin Cre+/-;Hnf4a fl/fl' vs 'wild type genotype' | genotype | Transcription profiling by array of liver-specific Hnf4alpha knock-out mice |
-4.2 | | Slc17a3 | 'confluent monolayer on collagen' at '7 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-4.1 | | Slc17a3 | 'cortical epithelial cell; Lin- Dapi-EpCAM+ CD31-UEA1-Ly51+ td-tomato+t vs 'medullary epithelial cell; Lin- Dapi-EpCAM+ CD31-UEA1+Ly51- td-tomato-' | cell type, phenotype | Thymic T-cell progenitor development is supported by membrane bound Kit ligand provided by a combined vascular endothelial and epithelial niche. |
-3.9 | | Slc17a3 | 'Plasmodium chabaudi infection' vs 'no infection' in 'adjuvant only' | infect, treatment | Protective vaccination against blood-stage malaria of Plasmodium chabaudi: differential gene expression in the liver of Balb/c mice towards the end of crisis phase |
3.8 | | Slc17a3 | 'clear cell sarcoma; Rosa26CreER' vs 'control' | disease, genotype | Mouse Model of Clear Cell Sarcoma |
-3.7 | | Slc17a3 | 'confluent monolayer on collagen' at '1 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-3.6 | | Slc17a3 | 'confluent monolayer on collagen' at '5 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-3.6 | | Slc17a3 | 'subconfluent monolayer on collagen' at '5 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-3.5 | | Slc17a3 | 'subconfluent monolayer on collagen' at '7 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-3.5 | | Slc17a3 | 'collagen sandwich' at '2 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-3.5 | | Slc17a3 | 'collagen sandwich' at '3 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-3.4 | | Slc17a3 | 'subconfluent monolayer on collagen' at '2 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-3.4 | | Slc17a3 | 'subconfluent monolayer on collagen' at '3 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-3.3 | | Slc17a3 | 'collagen sandwich' at '1 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
3.3 | | Slc17a3 | 'AZD7507; AZD5069 (at same dosage); 100 milligram per kilogram' vs 'none' | compound | RNA-seq to investigate differentially expressed genes in KPC mouse PDAC treated with CSF-1R small molecule inhibitor AZD7507 and/or the CXCR2 small molecule inhibitor AZD5069 |
-3.2 | | Slc17a3 | 'confluent monolayer on collagen' at '2 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-3.1 | | Slc17a3 | 'confluent monolayer on collagen' at '3 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
-2.9 | | Slc17a3 | 'collagen sandwich' at '7 day' vs 'freshly isolated' at '0 day' | growth condition, time | Transcription profiling of primary mouse hepatocytes under different culture conditions |
2.9 | | Slc17a3 | 'clear cell sarcoma; TATCre' vs 'control' | disease, genotype | Mouse Model of Clear Cell Sarcoma |
-2.8 | | Slc17a3 | 'tumor' vs 'normal' in 'kidney' | clinical information, organism part | Premature termination of in vivo reprogramming leads to cancer development through altered epigenetic regulation [array] |
-2.7 | | Slc17a3 | 'methionine- and choline-deficient, high fat diet' vs 'normal' | diet | Expression data from mouse liver treated with metformin |
-2.7 | | Slc17a3 | 'ko cyld-/-' vs 'wild type' | genotype | Transcription profiling by array of mouse liver with Cyld inactivation |
2.7 | | Slc17a3 | '365 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
-2.6 | | Slc17a3 | 'Lmna G609G/G609G knock in' vs 'wild type' | genotype | Transcription profiling by array of mouse liver with Lmna Gly609Gly knock in |
-2.6 | | Slc17a3 | 'Taf10-/-' vs 'wild type' | genotype | Transcription profiling by array of liver from Taf10 knock out mice |
2.6 | | Slc17a3 | '60 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
2.6 | | Slc17a3 | "98 to 119 week; reproductively old" vs "6 to 12 week; reproductively young" | age, phenotype | RNAseq of whole ovarian follicles from young and old mice. |
2.5 | | Slc17a3 | '14 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
2.5 | | Slc17a3 | 'extracellular vesicle; non-stimulated culture medium' vs 'none' | sampling site, stimulus | Cellular and extracellular vesicle RNA sequence for E-cadherin-RFP EMT reporter system expressing mouse breast cancer cell line Py2T during EMT/MET |
-2.4 | | Slc17a3 | 'liver-specific Cnot3 knockout' vs 'wild type' | phenotype | Roles of mRNA decay in liver development |
2.4 | | Slc17a3 | '90 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
2.4 | | Slc17a3 | '30 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
2.4 | | Slc17a3 | '7 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
-2.3 | | Slc17a3 | 'L-Pex5 knock-out' vs 'wild type' | genotype | Transcription profiling by array of liver from L-Pex5 knock-out mice |
-2.3 | | Slc17a3 | 'unilateral ureteral obstruction' vs 'sham' in 'TIMP3 -/-' | genotype, treatment | TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury |
2.3 | | Slc17a3 | '180 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
2.3 | | Slc17a3 | '730 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
-2.3 | | Slc17a3 | 'H-Ras expression' vs 'wild type' | phenotype | RNA-seq of heart tissue from 15 day old mice 4 hours post MycER activation compared to wild type controls. RNA-seq of heart tissues from adult mice that have expressed oncogenic H-Ras for 4 weeks followed by MycER activation for 4 hours compared to MycER negative controls. |
-2.2 | | Slc17a3 | 'methionine- and choline-deficient, high fat diet mixed with 0.1% metformin' vs 'normal' | diet | Expression data from mouse liver treated with metformin |
2.2 | | Slc17a3 | '21 day' vs '1 day' | age | Transcriptional profilling of female mice liver as a function of age |
2.2 | | Slc17a3 | 'extracellular vesicle; MET cell culture medium' vs 'none' | sampling site, stimulus | Cellular and extracellular vesicle RNA sequence for E-cadherin-RFP EMT reporter system expressing mouse breast cancer cell line Py2T during EMT/MET |
-2.1 | | Slc17a3 | 'tumor' vs 'normal' in 'liver' | clinical information, organism part | Premature termination of in vivo reprogramming leads to cancer development through altered epigenetic regulation [array] |
-2.1 | | Slc17a3 | 'interferon gamma; 10 nanogram per milliliter and interleukin-13; 10 nanogram per milliliter' vs 'none' | compound | RNAseq of small intestinal organoids from mice treated with the cytokines IFNG, IL-13 and IL-22 for 24 hours |
-2 | | Slc17a3 | 'Alb-Cre-ERT2 / Cnot1 flox/flox' vs 'Cnot1 flox/flox' in 'none' | compound, genotype, time | RNA-seq of livers in control and Cnot1 tamoxifen-inducible liver-specific knockout mice |
-2 | | Slc17a3 | 'wormy, worm left; Trichuris muris' vs 'control; non wormy' in 'caecum' | environmental stress, infect, organism part | RNA-seq of mouse intestinal mucosa to investigate infection by the parasitic nematode Trichuris muris |
-1.9 | | Slc17a3 | 'unilateral ureteral obstruction' vs 'sham' in 'wild type' | genotype, treatment | TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury |
-1.9 | | Slc17a3 | 'Alb-Cre;HIF1dPA/HIF2dPA' vs 'Alb-Cre' | genotype | Transcription profiling by array of mice with liver-specific expression of hypoxia inducible factor, or inactivated von Hippel-Lindau tumor suppressor |
-1.8 | | Slc17a3 | 'Nrl-/-' vs 'wild type' | genotype | Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and Nrl-/- Retinal Transcriptomes |
-1.8 | | Slc17a3 | 'Rb^{lox/lox}; p130^{lox/lox}; p107+/-' vs 'wild type' | genotype | Transcription profiling by array of livers from the mouse model of human hepatocellular carcinoma |
-1.8 | | Slc17a3 | 'Alb-Cre;VHLf/f' vs 'Alb-Cre' | genotype | Transcription profiling by array of mice with liver-specific expression of hypoxia inducible factor, or inactivated von Hippel-Lindau tumor suppressor |
-1.8 | | Slc17a3 | 'Plasmodium chabaudi infection' vs 'no infection' in 'vaccination' | infect, treatment | Protective vaccination against blood-stage malaria of Plasmodium chabaudi: differential gene expression in the liver of Balb/c mice towards the end of crisis phase |
1.8 | | Slc17a3 | 'SARS coronavirus MA15; 2 day' vs 'mock' in 'C57BL/6J' | infect, strain, time | Genomic profiling of collaborative cross founder mouse strains infected with respiratory viruses to discover novel transcripts and infection-related strain-specific gene and isoform expression |
-1.7 | | Slc17a3 | 'perfluorooctanoic acid; 10 milligram per kilogram per day' vs 'none' in 'liver' | block, compound, organism part | Transcription profiling of lung and liver from low and high dose Perfluorooctanoic Acid exposed fetuses |
-1.6 | | Slc17a3 | 'fasted' vs 're-fed' in 'wild type genotype; control miRNA' | RNA interference, diet, genotype | Gene expression profiling of liver from C57BLKS/J and db/db 8 mice with an AAV harboring a control or GAbpa-specific miRNA under the LP1 promoter |
-1.6 | | Slc17a3 | 'interleukin-13 (Mus musculus); 10 nanogram per milliliter' vs 'none' | compound | RNAseq of small intestinal organoids from mice treated with the cytokines IFNG, IL-13 and IL-22 for 24 hours |
-1.5 | | Slc17a3 | 'Ercc1 knock out' vs 'wild type' | genotype | Transcription profiling by array of liver from mice mutant for Ercc1 |
-1.5 | | Slc17a3 | 'diet restriction' vs 'control' | diet | Liver mRNA microarray study for mice treated with various diets |
-1.5 | | Slc17a3 | 'hepatocyte-specific Pten and Tgfbr2 knockout' vs 'wild type' | genotype | Hepatocyte-specific knockout of Pten and of Pten and Tgfbr2 in mice |
-1.5 | | Slc17a3 | 'hepatocyte-specific Pten knockout' vs 'wild type' | genotype | Hepatocyte-specific knockout of Pten and of Pten and Tgfbr2 in mice |
-1.4 | | Slc17a3 | 'Pten knockout' vs 'wild type' at '15 month' | genotype, time | Transcription profiling by array of Pten knockout liver cells of mouse |
-1.4 | | Slc17a3 | 'S6K1 knockout' vs 'wild type' in 'liver' | genotype, organism part | Transcription profiling of mouse long-lived S6K1 -/- strain females compared to wild types |
-1.3 | | Slc17a3 | 'fasted' vs 're-fed' in 'wild type genotype; Gabpa miRNA' | RNA interference, diet, genotype | Gene expression profiling of liver from C57BLKS/J and db/db 8 mice with an AAV harboring a control or GAbpa-specific miRNA under the LP1 promoter |
-1.3 | | Slc17a3 | 'interferon gamma; 10 nanogram per milliliter and interleukin-22; 10 nanogram per milliliter' vs 'none' | compound | RNAseq of small intestinal organoids from mice treated with the cytokines IFNG, IL-13 and IL-22 for 24 hours |
-1.2 | | Slc17a3 | 'Pkhd1Cre; Pkd2 F/F' vs 'wild type' | genotype | Next Generation Sequencing of PKD2 mutant mice kidneys |
-1.2 | | Slc17a3 | 'perfluorooctanoic acid; 5 milligram per kilogram per day' vs 'none' in 'liver' | block, compound, organism part | Transcription profiling of lung and liver from low and high dose Perfluorooctanoic Acid exposed fetuses |
-1.2 | | Slc17a3 | 'Crx knockout' vs 'control' at '6 zeitgeber' | genotype, time | Transcriptome in 129sv and Crx-/- pineal gland at ZT (Zeitgeber time) 6 and ZT20 |
-1.2 | | Slc17a3 | 'fasted' vs 're-fed' in 'db/db; control miRNA' | RNA interference, diet, genotype | Gene expression profiling of liver from C57BLKS/J and db/db 8 mice with an AAV harboring a control or GAbpa-specific miRNA under the LP1 promoter |
1.2 | | Slc17a3 | 'conditional UPF2 knockout' vs 'control' in 'embryonic day 18.5' | developmental stage, genotype | Transcription profiling of fetal livers of UPF2 null mice |
-1.2 | | Slc17a3 | 'control mice [Gp130f/f]; cecal ligation and puncture' vs 'control mice [Gp130f/f]; control' | genotype, treatment | Hepatic acute phase proteins control innate immune responses during infection by promoting myeloid derived suppressor cell function |
1.2 | | Slc17a3 | 'fetal definitive erythroid cell' vs 'primitive erythroid cell' in 'mix of orthochromatic and polychromatophilic erythroblast' | cell type, phenotype | Transcription profiling by array of differentiating primary primitive and definitive mouse red blood cells |
-1.2 | | Slc17a3 | 'Alb-Cre;HIF2dPA' vs 'Alb-Cre' | genotype | Transcription profiling by array of mice with liver-specific expression of hypoxia inducible factor, or inactivated von Hippel-Lindau tumor suppressor |
-1.2 | | Slc17a3 | 'Tetrafluororethane; 50000 part per million; air' vs 'none; ; air' | compound, treatment | Transcription profiling by array of Mus musculus liver tissue after exposure to various carcinogenic chemicals |
-1.2 | | Slc17a3 | 'Klf1-/-' vs 'wild type' | genotype | Novel roles for Klf1 in regulating the erythroid transcriptome revealed by mRNA-seq |
-1.1 | | Slc17a3 | 'CCl4; 1.6 gram per kilogram' at '8 hour' vs 'none' at '0 hour' | compound, time | Transcriptional responses in liver upon acute CCl4 intoxication |
-1.1 | | Slc17a3 | 'transgenic hepatic growth hormone' vs 'wild type genotype' in '12 week' | age, genotype | Hepatic Deletion of Janus Kinase 2 Counteracts Inflammation, Oxidative Stress and Liver Cancer Formation in Growth Hormone Transgenic Mice |
-1.1 | | Slc17a3 | 'fasted' vs 're-fed' in 'db/db; Gabpa miRNA' | RNA interference, diet, genotype | Gene expression profiling of liver from C57BLKS/J and db/db 8 mice with an AAV harboring a control or GAbpa-specific miRNA under the LP1 promoter |
-1.1 | | Slc17a3 | 'unilateral ureteral obstruction' vs 'sham' in 'TIMP2 -/-' | genotype, treatment | TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury |
-1 | | Slc17a3 | 'S-(1,2-dichlorovinyl)-L-cysteine; 15 milligram per kilogram; renal injury; 1 week' vs 'none; normal' | compound, disease, time | Expression profiling experiment on Pkd1-mutant mice and mice induced with nephrotoxin DCVC |
-1 | | Slc17a3 | 'liver-specific Cnot1 knockout' vs 'wild type' | phenotype | Roles of mRNA decay in liver development |
-1 | | Slc17a3 | 'NEMO-TNFR1 double knockout' vs 'wild type' | genotype | TNFR1 controls apoptosis and chronic liver disease in hepatocyte-specific IKKγ (Nemo) mice. |
-1 | | Slc17a3 | 'control; streptozotocin-induced diabetes' vs 'control; control' | diet, phenotype | Hepatic gene expression in streptozotocin-induced diabetic mice fed a phloridzin diet |
1 | | Slc17a3 | 'ZT18' vs 'ZT6' in 'dexamethasome; 1 milligram per kilogram; wild type genotype' | compound, genotype, time | RNASeq data analysis of wild type and reverb alpha knockout cells from mouse liver, at different time points, with or without DEX treatment |
-1 | | Slc17a3 | 'liver-specific Gp130 knockout mice [Gp130delta(hepa)]; cecal ligation and puncture' vs 'liver-specific Gp130 knockout mice [Gp130delta(hepa)]; control' | genotype, treatment | Hepatic acute phase proteins control innate immune responses during infection by promoting myeloid derived suppressor cell function |
-1 | | Slc17a3 | 'dexamethasome' vs 'methyl beta-clodextrin' in 'Nr1d1 homozygous knockout; 1 milligram per kilogram; ZT6' | compound, genotype, time | RNASeq data analysis of wild type and reverb alpha knockout cells from mouse liver, at different time points, with or without DEX treatment |
-1 | | Slc17a3 | 'acute graft vs. host disease' vs 'normal' | compound, disease | Transcription profiling by array of murine thymus medulla in the absence and presence of acute graft-versus-host disease |
1 | | Slc17a3 | 'fetal definitive erythroid cell' vs 'primitive erythroid cell' in 'proerythroblast' | cell type, phenotype | Transcription profiling by array of differentiating primary primitive and definitive mouse red blood cells |